Skip to main content
Purple to pink gradient background
COSENTYX Connect real support personal solutions.

COSENTYX® Connect is a support program for people taking or considering COSENTYX® (secukinumab). Sign up now for access to a full range of services and support, like access to a COSENTYX® Connect Team Member, the COSENTYX® Connect Co-Pay Program and pay as little as $0 co-pay if eligible,* and injection resources to make your experience with COSENTYX as easy, affordable, and convenient as possible.

For those who are taking COSENTYX, here's what you will get once you sign up:
Thumbnail

“COSENTYX® Connect has been great. They really care about me as a patient and take a genuine interest in how I’m doing.”


—Mike, actual patient enrolled in COSENTYX® Connect

Thumbnail

“You guys call and make sure that I have what I need, that I’m doing okay. It’s the best support system to help you.”


—Dewey, actual patient enrolled in COSENTYX® Connect

 Individual results may vary. Mike and Dewey were compensated for their time.

The Covered Until You're Covered Program is available for COSENTYX subcutaneous injection only. Eligible patients must have private insurance, a valid prescription for COSENTYX, and a denial of insurance coverage based on a prior authorization request. Program requires the submission of an appeal of the coverage denial within the first 90 days of enrollment in order to remain eligible. Program provides COSENTYX for free to eligible patients for up to two years, or until they receive insurance coverage approval, whichever occurs earlier. A valid prescription consistent with FDA-approved labeling is required. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Patients may be asked to reverify insurance coverage status during the course of the program. No purchase necessary. Program is not health insurance, nor is participation a guarantee of insurance coverage. Limitations may apply. Enrolled patients awaiting coverage for COSENTYX after two years may be eligible for a limited Program extension. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke, or amend this Program without notice.

*Limitations apply. Valid only for those with private insurance. Program provides up to $16,000 annually for the cost of COSENTYX and up to $150 per infusion (up to $1,950 annually) for the cost of administration. Co-pay support for infusion administration cost not available in Rhode Island or Massachusetts. Offer not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions for details.